
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Regulated Information Leuven, BELGIUM, Boston, MA, US – July 14, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular …